| Product Code: ETC8631141 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Opioid Use Disorder Drug Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Opioid Use Disorder Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Opioid Use Disorder Drug Market - Industry Life Cycle |
3.4 Nigeria Opioid Use Disorder Drug Market - Porter's Five Forces |
3.5 Nigeria Opioid Use Disorder Drug Market Revenues & Volume Share, By Buprenorphine, 2021 & 2031F |
4 Nigeria Opioid Use Disorder Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and recognition of opioid use disorder as a significant health issue in Nigeria |
4.2.2 Government initiatives and policies focusing on addressing substance abuse and improving access to treatment |
4.2.3 Growing pharmaceutical industry in Nigeria and advancements in opioid use disorder drug research and development |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities and treatment options in remote areas of Nigeria |
4.3.2 Stigma surrounding mental health and substance abuse disorders leading to underreporting and underdiagnosis |
4.3.3 Lack of trained healthcare professionals and resources to effectively manage opioid use disorder cases |
5 Nigeria Opioid Use Disorder Drug Market Trends |
6 Nigeria Opioid Use Disorder Drug Market, By Types |
6.1 Nigeria Opioid Use Disorder Drug Market, By Buprenorphine |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Opioid Use Disorder Drug Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.3 Nigeria Opioid Use Disorder Drug Market Revenues & Volume, By Methadone, 2021- 2031F |
6.1.4 Nigeria Opioid Use Disorder Drug Market Revenues & Volume, By Naltrexone, 2021- 2031F |
7 Nigeria Opioid Use Disorder Drug Market Import-Export Trade Statistics |
7.1 Nigeria Opioid Use Disorder Drug Market Export to Major Countries |
7.2 Nigeria Opioid Use Disorder Drug Market Imports from Major Countries |
8 Nigeria Opioid Use Disorder Drug Market Key Performance Indicators |
8.1 Number of opioid use disorder treatment centers and rehabilitation facilities in Nigeria |
8.2 Percentage of individuals seeking treatment for opioid use disorder compared to the total estimated affected population |
8.3 Rate of successful treatment outcomes and relapse prevention strategies implemented in opioid use disorder cases. |
9 Nigeria Opioid Use Disorder Drug Market - Opportunity Assessment |
9.1 Nigeria Opioid Use Disorder Drug Market Opportunity Assessment, By Buprenorphine, 2021 & 2031F |
10 Nigeria Opioid Use Disorder Drug Market - Competitive Landscape |
10.1 Nigeria Opioid Use Disorder Drug Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Opioid Use Disorder Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |